Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma

Overview of attention for article published in OncoTargets and therapy, May 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 19 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 30 publications that cite this research output.

30

The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.

XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo

Article in Biochemical Genetics (July 2024)

The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma

Article in Medicine (August 2023)

Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety

Article in Biomedicines (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.